NCT06760832

Brief Summary

Very low-birth-weight premature infants (VLBWs) are fed via nasal or oro-gastric tube for a long time because of the physiological inability to coordinate swallowing, sucking, and breathing until at least 34 weeks of gestational age. Both bolus and continuous feeding modes are widely described in the literature; both modes have specific risks and benefits, and there is no evidence in the literature as to which mode is best in terms of tolerance and adverse effects. To date, the characteristics of enteral feeding that are associated with better feeding tolerance and fewer adverse effects have not been uniquely documented. There are currently no data in the literature directly comparing different modes of enteral feeding tube management in the preterm VLBW infant. Therefore, our study aims to evaluate different modes of enteral feeding tube management (extemporaneous vs. permanent introduction/removal and oral vs. nasal introduction route) in order to optimize enteral feeding management of the VLBW infant.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
7mo left

Started Jul 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress90%
Jul 2020Dec 2026

Study Start

First participant enrolled

July 21, 2020

Completed
4.4 years until next milestone

First Submitted

Initial submission to the registry

December 1, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 7, 2025

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Expected
Last Updated

January 7, 2025

Status Verified

December 1, 2024

Enrollment Period

5.4 years

First QC Date

December 1, 2024

Last Update Submit

December 30, 2024

Conditions

Keywords

enteral feedingpreterm newbornsfull enteral feeding

Outcome Measures

Primary Outcomes (1)

  • Evaluate the tolerance to intermittent gastric tube placement versus permanent gastric tube maintenance in Very Low Birth Weight preterm infants who have achieved full enteral feeding

    tolerance of intermittent gastric tube placement versus permanent gastric tube maintenance in preterm VLBW infants

    From the 1st patient enrolled, up to 50th patient enrolled

Eligibility Criteria

Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population will consist of all preterm infants of gestational age \<32 weeks and/or neonatal weight \<1500 g born at sant'orsola hospital. Based on birth data of preterm infants with these characteristics, it is estimated that within one year, approximately 50 infants will be enrolled

You may qualify if:

  • Gestational Age \<32 weeks and/or neonatal weight \<1500 g
  • Achievement of full enteral feeding (150 ml/kg/day of milk)
  • Exclusive feeding of human milk (breast and/or bank)
  • Informed consent signed by parent or legal guardian

You may not qualify if:

  • Need for invasive ventilatory support
  • Congenital malformations affecting the gastrointestinal tract

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Bologna, Bolgona, 40138, Italy

RECRUITING

MeSH Terms

Conditions

Premature Birth

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Arianna Aceti, MD

    IRCCS Azienda Ospedaliero-Universitaria di Bologna

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Arianna Aceti, MD

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 1, 2024

First Posted

January 7, 2025

Study Start

July 21, 2020

Primary Completion

December 31, 2025

Study Completion (Estimated)

December 31, 2026

Last Updated

January 7, 2025

Record last verified: 2024-12

Locations